Bank of America’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,076,061
| Closed | -$91.5M | – | 7597 |
|
|
2020
Q3 | $91.5M | Buy |
1,076,061
+253,396
| +31% | +$12.8M | 0.01% | 768 |
|
|
2020
Q2 | $29.2M | Buy |
822,665
+149,186
| +22% | +$4.36M | ﹤0.01% | 1352 |
|
|
2020
Q1 | $9.08M | Sell |
673,479
-162,966
| -19% | -$2.74M | ﹤0.01% | 2140 |
|
|
2019
Q4 | $17.7M | Buy |
836,445
+156,947
| +23% | +$2.77M | ﹤0.01% | 2001 |
|
|
2019
Q3 | $9.01M | Sell |
679,498
-52,637
| -7% | -$774K | ﹤0.01% | 2616 |
|
|
2019
Q2 | $10.2M | Sell |
732,135
-619,950
| -46% | -$9.33M | ﹤0.01% | 2544 |
|
|
2019
Q1 | $26M | Buy |
1,352,085
+279,544
| +26% | +$4.51M | ﹤0.01% | 1597 |
|
|
2018
Q4 | $15.3M | Buy |
1,072,541
+990,394
| +1,206% | +$19.7M | ﹤0.01% | 1909 |
|
|
2018
Q3 | $1.71M | Sell |
82,147
-58,800
| -42% | -$1.39M | ﹤0.01% | 4112 |
|
|
2018
Q2 | $3.34M | Buy |
140,947
+73,519
| +109% | +$1.48M | ﹤0.01% | 3539 |
|
|
2018
Q1 | $985K | Sell |
67,428
-2,811
| -4% | -$45.9K | ﹤0.01% | 4391 |
|
|
2017
Q4 | $1.14M | Buy |
70,239
+3,507
| +5% | +$41.4K | ﹤0.01% | 4402 |
|
|
2017
Q3 | $933K | Buy |
66,732
+33,630
| +102% | +$335K | ﹤0.01% | 4561 |
|
|
2017
Q2 | $292K | Sell |
33,102
-605
| -2% | -$4.25K | ﹤0.01% | 5145 |
|
|
2017
Q1 | $218K | Sell |
33,707
-2,074
| -6% | -$10.5K | ﹤0.01% | 5276 |
|
|
2016
Q4 | $131K | Buy |
35,781
+22,377
| +167% | +$66.2K | ﹤0.01% | 5509 |
|
|
2016
Q3 | $44K | Sell |
13,404
-6,992
| -34% | -$19.6K | ﹤0.01% | 5777 |
|
|
2016
Q2 | $48K | Buy |
20,396
+9,296
| +84% | +$31.1K | ﹤0.01% | 5850 |
|
|
2016
Q1 | $28K | Sell |
11,100
-16,275
| -59% | -$36.6K | ﹤0.01% | 6007 |
|
|
2015
Q4 | $84K | Buy |
27,375
+23,297
| +571% | +$65K | ﹤0.01% | 5807 |
|
|
2015
Q3 | $7K | Sell |
4,078
-11,738
| -74% | -$30K | ﹤0.01% | 6689 |
|
|
2015
Q2 | $64K | Buy |
15,816
+12,216
| +339% | +$49.9K | ﹤0.01% | 5817 |
|
|
2015
Q1 | $14K | Sell |
3,600
-1,750
| -33% | -$7.61K | ﹤0.01% | 6197 |
|
|
2014
Q4 | $26K | Sell |
5,350
-5,637
| -51% | -$22.3K | ﹤0.01% | 6683 |
|
|
2014
Q3 | $41K | Buy |
10,987
+3,924
| +56% | +$13.3K | ﹤0.01% | 6647 |
|
|
2014
Q2 | $26K | Buy |
7,063
+4,200
| +147% | +$15.4K | ﹤0.01% | 7054 |
|
|
2014
Q1 | $13K | Sell |
2,863
-16,137
| -85% | -$80K | ﹤0.01% | 7105 |
|
|
2013
Q4 | $87K | Buy |
19,000
+13,975
| +278% | +$62.2K | ﹤0.01% | 6232 |
|
|
2013
Q3 | $31K | Sell |
5,025
-4,922
| -49% | -$28.3K | ﹤0.01% | 6687 |
|
|
2013
Q2 | $54K | Buy |
+9,947
| New | +$32.7K | ﹤0.01% | 6514 |
|
Bank of America's IMMU Position: Q4 2020 in Review
Bank of America sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,076,061 shares — an estimated $91.5M sold.
Bank of America first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $91.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Bank of America reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Bank of America sold 1,076,061 Immunomedics Inc shares in Q4 2020, an estimated $91.5M.
- Bank of America first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- Bank of America's Immunomedics Inc position peaked at $91.5M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Bank of America's 13F filing for Q4 2020, filed 10 Feb 2021.